Lanchun Duan

Lanchun Duan

Signal active

Managing Partner

Bio

Lanchun is a Managing Partner of Cathay Capital, based in Shanghai.

Lanchun joined Cathay Capital in 2010, and brings to the firm 10 years of audit and transaction services experience in China.

Prior to Cathay Capital, Lanchun was an Associate Director with Deloitte & Touch Corporate Finance in China. In her role, she led the financial review and valuation of M&A targets, and assisted with regulatory compliance and structures of deals, for many corporate and private equity firms. Representative clients included 3i, Blackstone, Carlyle, Merrill Lynch, SAIF Investment, Sumitomo, Shell, Iveco, Baosteel, China Resources, Jinjiang Group, Shanghai Auto Industrial Group.

Previously, Lanchun was an Assistant Business Manager of Brian Jessel BMW in Vancouver, Canada. Prior to that, and out of undergraduate school, Lanchun spent 3 years as a Senior Accountant at PricewaterhouseCoopers in Beijing, where she performed IPO audits for large Chinese companies.

Lanchun holds a bachelor degree in Accounting from the Central University of Finance and Economics in Beijing. She is also graduated from the Simon Fraser University Business School in Canada, and CEIBS in Shanghai (executive MBA).

Location

Shanghai, Shanghai, China, Asia

Social

N/A

Primary Organization

Cathay Innovation

Cathay Innovation

Founded

2015

Investment

130

Lead investment

54

Exits

12

Employees

11-50

Industry

Financial Services, Venture Capital, Finance

Jobs history

0

N/A

Board and Advisor Roles

0

N/A

Invest in regions

Profile Resume

Lanchun Duan is the Managing Partner at Cathay Innovation, based in Asia. With a background in Financial Services, Lanchun Duan has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.

Recommendation from your interest

N/A

Investment portfolio

N/A

Number of investment

1

Number of exits

0

Personal investment

0

There is no personal investment available on this profile

Partner investment

4

Annouced DateOrganization NameFunding RoundInvestor NameMoney Raised
Apr 07, 2021
PackGene Biotech PackGene Biotech
Series C - PackGene Biotech
PackGene Biotech Cathay Capital
0
Apr 24, 2023
Weining Technology Weining Technology
Series C - Weining Technology
Weining Technology Cathay Capital
43.5M
Jan 08, 2024
Huiying Medical Huiying Medical
Series B - Huiying Medical
Huiying Medical Cathay Capital
14.1M
Feb 21, 2024
Bio-Link Bio-Link
Series A - Bio-Link
Bio-Link Cathay Capital
0

Exits

0

There is no exit available on this Profile

Invest in industries

Recent Activity

There is no recent news or activity for this profile.